WINSUNBIO
839729
HIGO
872351
DRIVE
838275
4
Shanghai Menon Animal Nutrition Technology
301156
5
Nanjing Railway New Technology
301016
CN Stock MarketDetailed Quotes
600789 Shandong Lukang Pharmaceutical
- 11.33
- +0.18+1.61%
Market Closed Apr 3 15:00 CST
10.18BMarket Cap25.81P/E (TTM)
11.97High11.18Low2.33MlotVolume11.18Open11.15Pre Close2.70BTurnover25.92%Turnover Ratio25.81P/E (Static)898.67MShares12.7052wk High2.60P/B10.18BFloat Cap5.5652wk Low12.27Limit Up898.67MShs Float19.42Historical High10.04Limit Down7.09%Amplitude0.54Historical Low0.11Dividend TTM11.58Avg Price1.11MlotAsk0.97%Div YieldTTM100Lot Size1.10MlotBid
Shandong Lukang Pharmaceutical Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -1.42%5.28B | -0.76%3.43B | -2.48%2.33B | 18.44%1.23B | 33.48%5.36B | 9.92%3.45B | 17.97%2.39B | -0.58%1.03B | -0.62%4.01B | 12.59%3.14B |
| Refunds of taxes and levies | 136.10%68.8M | 127.29%70.46M | 81.89%47.62M | 16.68%21.22M | -75.16%29.14M | -70.63%31M | -46.68%26.18M | -23.85%18.18M | 116.96%117.33M | 8.46%105.56M |
| Cash received relating to other operating activities | 5.99%171.25M | -12.69%287.26M | -5.22%202.56M | 45.61%75.49M | 90.38%161.57M | 69.81%329.02M | 76.58%213.72M | -0.11%51.85M | -19.62%84.87M | 51.95%193.76M |
| Cash inflows from operating activities | -0.48%5.52B | -0.75%3.79B | -1.86%2.58B | 19.69%1.32B | 31.60%5.55B | 10.82%3.81B | 19.75%2.63B | -1.06%1.1B | 0.42%4.21B | 14.12%3.44B |
| Goods services cash paid | 7.39%3.49B | 1.75%2.2B | 11.27%1.58B | 20.48%765.44M | 35.86%3.25B | -3.90%2.16B | -10.68%1.42B | -14.29%635.31M | -11.15%2.39B | 14.42%2.25B |
| Staff behalf paid | -1.28%739.9M | 6.61%517.62M | 6.03%357.76M | 16.97%176.74M | 6.62%749.51M | 14.69%485.53M | 14.81%337.41M | -5.02%151.09M | 7.31%702.99M | 7.01%423.35M |
| All taxes paid | -23.42%199.35M | -21.16%164.11M | -6.96%133.13M | -3.84%70.94M | 42.10%260.3M | 35.28%208.16M | 108.99%143.09M | 171.72%73.78M | 15.86%183.19M | 15.29%153.88M |
| Cash paid relating to other operating activities | 0.68%684.07M | 0.30%504.24M | -5.27%324.84M | 28.67%146.46M | 38.79%679.43M | 48.29%502.75M | 51.62%342.9M | -5.99%113.82M | -4.29%489.53M | 2.23%339.04M |
| Cash outflows from operating activities | 3.53%5.12B | 0.82%3.38B | 6.80%2.4B | 19.05%1.16B | 31.09%4.94B | 6.09%3.35B | 2.97%2.25B | -7.11%974M | -6.21%3.77B | 11.99%3.16B |
| Net cash flows from operating activities | -33.31%402.82M | -12.13%404.71M | -52.32%183.73M | 24.42%162.85M | 35.92%604.01M | 64.04%460.58M | 2,276.33%385.32M | 92.05%130.89M | 150.36%444.38M | 45.17%280.77M |
| Investing cash flow | ||||||||||
| Cash received from returns on investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 9.09%29.52K | ---- |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 58,878.81%20.31M | 16,799.08%20.15M | --165.75K | ---- | -77.13%34.44K | 186.68%119.26K | ---- | ---- | -88.73%150.58K | 593.33%41.6K |
| Net cash received from disposal of subsidiaries and other business units | ---- | ---- | ---- | ---- | --2.13M | ---- | ---- | ---- | ---- | ---- |
| Cash received relating to other investing activities | ---- | ---- | ---- | --110K | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from investing activities | 836.61%20.31M | 16,799.08%20.15M | --165.75K | --110K | 1,104.13%2.17M | 186.68%119.26K | --0 | ---- | -86.78%180.1K | -99.60%41.6K |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -17.38%279.18M | -33.07%164.12M | -31.03%113.13M | 99.40%83.01M | -21.11%337.91M | 54.62%245.2M | 60.65%164.03M | -2.37%41.63M | -12.32%428.36M | -40.94%158.58M |
| Cash paid to acquire investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -62.48%15.82M | 7,052.96%77.89M |
| Cash paid relating to other investing activities | ---- | -19.53%32.76M | -25.13%20.47M | -12.88%11.63M | --34.03M | -6.15%40.71M | 81.88%27.34M | 331.56%13.35M | ---- | -13.80%43.38M |
| Cash outflows from investing activities | -24.94%279.18M | -31.14%196.88M | -30.19%133.6M | 72.13%94.65M | -16.26%371.94M | 2.17%285.91M | 59.29%191.38M | 12.82%54.99M | -17.09%444.19M | -12.53%279.85M |
| Net cash flows from investing activities | 29.99%-258.87M | 38.16%-176.73M | 30.27%-133.44M | -71.93%-94.54M | 16.72%-369.78M | -2.14%-285.79M | -59.29%-191.38M | -12.82%-54.99M | 16.92%-444.01M | 9.58%-279.81M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | -71.95%17.36M | -37.84%17.36M | -51.24%7.48M | -99.15%121.15K | 48.19%61.88M | 17.76%27.92M | 35.01%15.33M | 90.39%14.27M | 2,006.80%41.76M | --23.71M |
| Cash from borrowing | -23.07%1.68B | -47.26%904M | -53.86%490M | -60.47%270M | 1.61%2.18B | 53.56%1.71B | 85.03%1.06B | 209.28%683M | -16.78%2.14B | -42.67%1.12B |
| Cash received relating to other financing activities | 1,988.61%165M | ---- | ---- | ---- | 690.00%7.9M | ---- | ---- | ---- | --1M | ---- |
| Adjustment items of financing cash inflows | ---- | ---- | ---- | ---- | ---- | --0.32 | ---- | ---- | ---- | ---- |
| Cash inflows from financing activities | -17.35%1.86B | -47.11%921.36M | -53.82%497.48M | -61.26%270.12M | 2.81%2.25B | 52.81%1.74B | 84.06%1.08B | 205.38%697.27M | -15.19%2.19B | -41.46%1.14B |
| Borrowing repayment | -16.31%1.71B | -45.72%959.81M | -58.18%462.48M | -61.17%315M | 3.79%2.05B | 73.42%1.77B | 128.71%1.11B | 295.68%811.19M | -7.97%1.97B | -42.76%1.02B |
| Dividend interest payment | 62.45%233.49M | 23.85%149.85M | 112.13%107.32M | -43.87%13.51M | 2.96%143.73M | 5.76%120.99M | -2.39%50.59M | -25.54%24.07M | -16.61%139.59M | -0.41%114.4M |
| Cash payments relating to other financing activities | -33.58%100.56M | ---- | ---- | --3.34K | 88.58%151.4M | ---- | ---- | ---- | 1,081.95%80.29M | ---- |
| Adjustment items of financing cash outflows | ---- | ---- | ---- | ---- | ---- | ---0.3 | ---- | ---- | ---- | ---- |
| Cash outflows from financing activities | -12.59%2.05B | -41.26%1.11B | -50.74%569.8M | -60.67%328.52M | 6.85%2.34B | 66.60%1.89B | 116.02%1.16B | 251.92%835.27M | -5.40%2.19B | -40.29%1.13B |
| Adjustment items of net financing cash flow | ---- | ---- | ---- | ---- | ---- | ---0.6 | ---- | ---- | ---- | ---- |
| Net cash flows from financing activities | -101.33%-189.1M | -27.90%-188.3M | 8.77%-72.32M | 57.68%-58.4M | -1,669.32%-93.92M | -2,578.93%-147.23M | -258.83%-79.28M | -1,430.12%-138M | -102.03%-5.31M | -87.64%5.94M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 300.25%10.81M | 367.88%5.69M | 480.79%7.87M | 107.98%130.12K | -58.18%2.7M | -40.25%1.22M | 29.36%1.36M | -108.09%-1.63M | 680.23%6.46M | 85.68%2.04M |
| Adjustment items effecting cash and cash equivalents | ---- | ---- | ---- | ---- | ---- | ---0.02 | ---- | ---- | ---- | ---- |
| Net increase in cash and cash equivalents | -124.02%-34.34M | 57.72%45.38M | -112.20%-14.16M | 115.77%10.05M | 9,307.10%143.01M | 221.93%28.77M | 319.07%116.03M | -762.93%-63.72M | 101.60%1.52M | 113.36%8.94M |
| Add:Begin period cash and cash equivalents | 36.95%530.05M | 36.95%530.05M | 36.95%530.05M | 36.95%530.05M | 0.39%387.04M | -0.04%387.04M | -0.04%387.04M | 0.39%387.04M | -19.73%385.52M | -19.39%387.18M |
| End period cash equivalent | -6.48%495.7M | 38.39%575.42M | 2.55%515.89M | 67.05%540.09M | 36.95%530.05M | 4.97%415.81M | 50.52%503.07M | -18.18%323.31M | 0.39%387.04M | -4.18%396.11M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | Hexin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Shanghui Certified Public Accountants (Special General Partnership) | -- | -- | -- | Shanghui Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.